RWAYZ

["David Spreng discussed third quarter financial highlights, strategy, and the merger with SWK Holdings.", "Greg Greifeld expanded on portfolio activity, including 11 investments in the quarter and the strategic fit of SWK's portfolio in healthcare and life sciences.", "Tom Raterman detailed financial results, including total investment income, net investment income, portfolio risk metrics, and the impact of the SWK acquisition on financial profile, expecting mid-single-digit run rate net investment income accretion and enhanced earnings power post-close.", "The acquisition of SWK is seen as strategic, providing diversification, scaling the portfolio, optimizing leverage, and enhancing yield and expense efficiency."]

["The merger with SWK is expected to be accretive in the first full quarter after closing, with the close anticipated in early 2026, subject to SEC regulatory approval delays due to the government shutdown.", "The transaction is projected to scale the portfolio to $1.2 billion pro forma, optimize leverage to around 1.1x, and provide incremental yield and expense efficiency.", "The Board approved a $25 million stock repurchase program, with 397,983 shares repurchased in the third quarter, limited by the blackout period related to the SWK transaction."]

Runway Growth Finance reported total investment income of $36.7 million and net investment income of $15.7 million for the third quarter of 2025. The weighted average portfolio risk rating increased to 2.42, and the dollar-weighted loan-to-value ratio went from 29.6% to 31.4%. The total investment portfolio had a fair value of $946 million, a decrease from $1.02 billion in the previous quarter. The acquisition of SWK Holdings is expected to scale the portfolio by an estimated $242 million, with SWK's portfolio in healthcare and life sciences increasing Runway's exposure in that sector to approximately 31% of the overall portfolio at fair value from 14% previously. Runway completed 11 investments in the third quarter, totaling $128.3 million in funded loans, including investments in federal hearings and appeals services, DigiCert Inc., and existing portfolio companies like King Insurance and Madison Reed.

["Uncertainties in market conditions caused by interest rate uncertainties, changing economic conditions, and other factors identified in SEC filings.", "Delays in the SEC regulatory approval process due to the ongoing government shutdown, potentially impacting the close of the SWK merger.", "Competitive dynamics and pricing pressures in the venture debt space, including spread compression."]

Q: How should we think about origination activity and repayment activity in 4Q given the SWK merger?

A: Repayments are likely muted relative to Q3, and origination is utilizing the pipeline and BC Partners Credit platform.

Q: What's the yield profile between Runway's existing portfolio and SWK's?

A: SWK's portfolio has a slightly higher yield, and once integrated, there may be opportunities to upsize best loans.

Q: Which portfolio companies drove realized losses and unrealized depreciation?

A: Losses were mainly in the equity portfolio, due to warrant expirations and liquidation of IPO shares, mostly idiosyncratic.

Q: What's driving prepayment activity?

A: M&A activity and companies finding cheaper refinancing options; normal course of prepayments expected to continue.

Q: Competitive dynamics in venture debt?

A: Spread compression seen, but less than broader markets; expected to continue with rate drops.

Q: Integration of SWK team?

A: SWK team will assist with transition, portfolio relationships, and new originations.

Q: Dividend decision with NII per share higher than dividend?

A: Dividend covers base with Q4 earnings, considering prepayment-related income and rebuilding portfolio.

Q: Characteristics of loan in Cadma JV?

A: Growth loan, similar to Runway's deals but better suited for the JV.

Q: PIK income breakdown and underwriting?

A: Structured PIK varies by deal, underwritten with focus on loan-to-value considering accrued PIK.

Q: Accretion of the deal in 2026?

A: Expected to be accretive in the first full quarter after closing, pending timely close.

Q: Fair value reevaluation of SWK assets?

A: Fair value marked at closing, with prospect of OID accretion.

Q: Share issuance in SWK merger?

A: NAV for NAV merger, issued at current NAV 48 hours before closing.

Q: Stage of companies SWK invests in?

A: Generating meaningful revenue, growth phase, still pre-profit, similar to Runway's target sectors.